Fidelity International Enhanced Index Fund OCSE:NOVO B Holdings History
Fidelity International Enhanced Index Fund's Novo Nordisk AS Holding Summary
As of 2023-08-31, Fidelity Commonwealth Trust II held 375,606.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr34.64 Mil. This investment constitutes 2.25% of their stock portfolio, and Fidelity Commonwealth Trust II now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2022Q1. And since then Fidelity International Enhanced Index Fund has made 2 purchases of OCSE:NOVO B, at an average price of kr357.80, for a total of 444,896.00 shares. In addition, there have been 4 sales at an average price of kr478.91 for 69,290.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr410.90, Fidelity International Enhanced Index Fund's estimated gain on his OCSE:NOVO B holdings is kr28.34 Mil, reflecting a 17.80% gain to date.
Fidelity International Enhanced Index Fund OCSE:NOVO B (kr410.90) Holding Chart
Fidelity International Enhanced Index Fund OCSE:NOVO B (kr410.90) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
